vs
Side-by-side financial comparison of Apyx Medical Corp (APYX) and Idaho Strategic Resources, Inc. (IDR). Click either name above to swap in a different company.
Apyx Medical Corp is the larger business by last-quarter revenue ($19.2M vs $14.6M, roughly 1.3× Idaho Strategic Resources, Inc.). Idaho Strategic Resources, Inc. runs the higher net margin — 64.3% vs -6.8%, a 71.1% gap on every dollar of revenue. On growth, Idaho Strategic Resources, Inc. posted the faster year-over-year revenue change (92.0% vs 34.7%). Idaho Strategic Resources, Inc. produced more free cash flow last quarter ($8.2M vs $-2.8M). Over the past eight quarters, Idaho Strategic Resources, Inc.'s revenue compounded faster (57.2% CAGR vs 36.8%).
Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.
Idaho Strategic Resources, Inc.IDREarnings & Financial Report
Idaho Strategic Resources, Inc. is a U.S.-based natural resource company focused on the exploration, development, and production of critical and strategic minerals. Primarily operating in Idaho, it targets rare earth elements, gold, silver, and other high-demand minerals, supplying products to the clean energy, defense, and industrial manufacturing sectors across North America.
APYX vs IDR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $14.6M |
| Net Profit | $-1.3M | $9.4M |
| Gross Margin | 62.6% | 68.5% |
| Operating Margin | 0.1% | 62.4% |
| Net Margin | -6.8% | 64.3% |
| Revenue YoY | 34.7% | 92.0% |
| Net Profit YoY | 71.9% | 220.6% |
| EPS (diluted) | — | $0.62 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.2M | $14.6M | ||
| Q3 25 | $12.9M | $11.1M | ||
| Q2 25 | $11.4M | $9.5M | ||
| Q1 25 | $9.4M | $7.3M | ||
| Q4 24 | $14.2M | $7.6M | ||
| Q3 24 | $11.5M | $6.2M | ||
| Q2 24 | $12.1M | $6.1M | ||
| Q1 24 | $10.2M | $5.9M |
| Q4 25 | $-1.3M | $9.4M | ||
| Q3 25 | $-2.0M | $3.0M | ||
| Q2 25 | $-3.8M | $2.8M | ||
| Q1 25 | $-4.2M | $1.6M | ||
| Q4 24 | $-4.6M | $2.9M | ||
| Q3 24 | $-4.7M | $1.6M | ||
| Q2 24 | $-6.6M | $2.2M | ||
| Q1 24 | $-7.6M | $2.2M |
| Q4 25 | 62.6% | 68.5% | ||
| Q3 25 | 64.4% | 63.6% | ||
| Q2 25 | 62.3% | 57.8% | ||
| Q1 25 | 60.1% | 50.8% | ||
| Q4 24 | 63.0% | 53.3% | ||
| Q3 24 | 60.5% | 48.7% | ||
| Q2 24 | 61.7% | 50.2% | ||
| Q1 24 | 58.1% | 48.1% |
| Q4 25 | 0.1% | 62.4% | ||
| Q3 25 | -6.5% | 23.4% | ||
| Q2 25 | -22.6% | 26.6% | ||
| Q1 25 | -32.4% | 19.3% | ||
| Q4 24 | -21.4% | 36.2% | ||
| Q3 24 | -31.6% | 23.4% | ||
| Q2 24 | -45.7% | 34.2% | ||
| Q1 24 | -64.6% | 36.3% |
| Q4 25 | -6.8% | 64.3% | ||
| Q3 25 | -15.4% | 26.8% | ||
| Q2 25 | -33.2% | 29.2% | ||
| Q1 25 | -44.0% | 22.1% | ||
| Q4 24 | -32.5% | 38.5% | ||
| Q3 24 | -40.9% | 25.8% | ||
| Q2 24 | -54.0% | 35.2% | ||
| Q1 24 | -74.0% | 36.8% |
| Q4 25 | — | $0.62 | ||
| Q3 25 | — | $0.20 | ||
| Q2 25 | — | $0.20 | ||
| Q1 25 | — | $0.12 | ||
| Q4 24 | — | $0.21 | ||
| Q3 24 | — | $0.12 | ||
| Q2 24 | $-0.19 | $0.17 | ||
| Q1 24 | $-0.22 | $0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | — |
| Total DebtLower is stronger | $37.5M | $2.3M |
| Stockholders' EquityBook value | $14.5M | $108.2M |
| Total Assets | $66.8M | $116.2M |
| Debt / EquityLower = less leverage | 2.58× | 0.02× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.7M | — | ||
| Q3 25 | $25.1M | — | ||
| Q2 25 | $29.3M | — | ||
| Q1 25 | $31.0M | — | ||
| Q4 24 | $31.7M | — | ||
| Q3 24 | $28.0M | — | ||
| Q2 24 | $32.7M | $6.3M | ||
| Q1 24 | $37.3M | $5.3M |
| Q4 25 | $37.5M | $2.3M | ||
| Q3 25 | $37.5M | $3.0M | ||
| Q2 25 | $37.5M | $3.3M | ||
| Q1 25 | $37.5M | $3.7M | ||
| Q4 24 | $37.5M | $1.7M | ||
| Q3 24 | $37.5M | $2.9M | ||
| Q2 24 | — | $2.7M | ||
| Q1 24 | — | $3.3M |
| Q4 25 | $14.5M | $108.2M | ||
| Q3 25 | $5.8M | $74.3M | ||
| Q2 25 | $7.3M | $49.3M | ||
| Q1 25 | $10.5M | $39.8M | ||
| Q4 24 | $14.2M | $37.7M | ||
| Q3 24 | $11.0M | $33.1M | ||
| Q2 24 | $14.7M | $25.4M | ||
| Q1 24 | $20.3M | $21.6M |
| Q4 25 | $66.8M | $116.2M | ||
| Q3 25 | $57.4M | $83.1M | ||
| Q2 25 | $58.2M | $57.7M | ||
| Q1 25 | $60.2M | $48.1M | ||
| Q4 24 | $64.8M | $44.0M | ||
| Q3 24 | $60.7M | $40.8M | ||
| Q2 24 | $65.4M | $32.2M | ||
| Q1 24 | $70.7M | $28.7M |
| Q4 25 | 2.58× | 0.02× | ||
| Q3 25 | 6.41× | 0.04× | ||
| Q2 25 | 5.17× | 0.07× | ||
| Q1 25 | 3.57× | 0.09× | ||
| Q4 24 | 2.64× | 0.05× | ||
| Q3 24 | 3.40× | 0.09× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.15× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $10.7M |
| Free Cash FlowOCF − Capex | $-2.8M | $8.2M |
| FCF MarginFCF / Revenue | -14.6% | 56.0% |
| Capex IntensityCapex / Revenue | 1.4% | 17.7% |
| Cash ConversionOCF / Net Profit | — | 1.15× |
| TTM Free Cash FlowTrailing 4 quarters | $-9.1M | $12.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.5M | $10.7M | ||
| Q3 25 | $-3.5M | $2.4M | ||
| Q2 25 | $-1.2M | $3.5M | ||
| Q1 25 | $-702.0K | $2.4M | ||
| Q4 24 | $-2.9M | $3.2M | ||
| Q3 24 | $-4.4M | $2.5M | ||
| Q2 24 | $-4.3M | $2.6M | ||
| Q1 24 | $-6.3M | $2.6M |
| Q4 25 | $-2.8M | $8.2M | ||
| Q3 25 | $-4.1M | $709.8K | ||
| Q2 25 | $-1.5M | $2.5M | ||
| Q1 25 | $-757.0K | $1.0M | ||
| Q4 24 | $-3.2M | $2.1M | ||
| Q3 24 | $-4.6M | $1.9M | ||
| Q2 24 | $-4.6M | $2.4M | ||
| Q1 24 | $-6.4M | $2.3M |
| Q4 25 | -14.6% | 56.0% | ||
| Q3 25 | -31.5% | 6.4% | ||
| Q2 25 | -13.2% | 26.5% | ||
| Q1 25 | -8.0% | 13.8% | ||
| Q4 24 | -22.4% | 28.0% | ||
| Q3 24 | -40.0% | 30.4% | ||
| Q2 24 | -38.0% | 38.7% | ||
| Q1 24 | -62.2% | 38.3% |
| Q4 25 | 1.4% | 17.7% | ||
| Q3 25 | 4.0% | 15.3% | ||
| Q2 25 | 2.3% | 10.8% | ||
| Q1 25 | 0.6% | 19.4% | ||
| Q4 24 | 1.7% | 13.6% | ||
| Q3 24 | 1.3% | 9.8% | ||
| Q2 24 | 2.4% | 4.3% | ||
| Q1 24 | 0.3% | 5.5% |
| Q4 25 | — | 1.15× | ||
| Q3 25 | — | 0.81× | ||
| Q2 25 | — | 1.28× | ||
| Q1 25 | — | 1.50× | ||
| Q4 24 | — | 1.08× | ||
| Q3 24 | — | 1.56× | ||
| Q2 24 | — | 1.22× | ||
| Q1 24 | — | 1.19× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
